RESEARCH GRANT AWARDS

Tumor-derived LPA immune suppression of CD8 T cell tumor immunity

The role of the Androgen Receptor in obesity-associated postmenopausal breast cancer

Combination Therapies for Young Patients with late state colorectal cancer

A novel preclinical model to test Iloprost and PPAR delta antagonist in lung cancer chemoprevention

Role of EphB4 in radiosensitization in PDX model of head and neck cancer

Identification and characterization of GON4L as a novel regulator of oncogene CD24 in bladder cancer

Novel Assessment of Neuropsychological Difficulties in Children (NAND-Child)

Targeting breast cancer stem cells by inhibiting glucose metabolism

The anti-cancer mechanism of Il-37

Activation of NK cells for immunotherapy of lung tumors

Identifying Molecular Targets in Melanoma Resistant to Braf/Mek Combination Therapy

Role of Mammalian Sterile 20 like kinase 4 (MSTA) in Pediatric Brain Cancer

Approaches to Targeted Therapy in Adrenal Carcinogenesis

Systems analysis of EGFR-inhibitor induced kinome reprograming and EMT in non-small cell lung cancer

Selective targeting of drug-induced autophagy to improve cancer therapy

Redox-targeted therapy for the treatment of FLT3 mutated leukemia

How does miRNA modulation of mRNA structure regulate production of a pro-tumor chemokine receptor?

Leukemia-cell Calcineurin as a central mediator of immune evasion

Consequences of TP63 loss on human skin squamous cell carcinogenesis

Cancer Research Summer Fellowship Program

A Novel Approach to Reveal the Impact of Genetic Mutations on Cancer Genome Stability

Functional analysis of EBF1:PDGFRB, a novel oncoprotein

Quiescent estrogen receptor positive cells as a source of breast cancer recurrence

Combined ATRA and Ipillmuma treatment to reduce immunosuppression in melanoma patients

Role of PBRM1 mutation in clear cell renal cell carcinoma

Evaluation of pharmacologic inhibition of histone demethylases in Ewing Sarcoma

Developing stapled peptides for breast cancer theraphy

The effect of inhibiting splicing factor Snu114 in cancer

Grhl2 Developmental Network to Identify Novel Suppressors of EMT in Breast Cancer

Characterizing the activation status of inflammatory infiltrates in persistent and regressive premalignanat bronchial dysplasia

The function of tumor infiltrating B cells in non small cell lung cancer patients

Kinome Essential Screen for Discovery of Novel Targets in Small Cell Lung Cancer

Elucidating the roles of midbodies during squamous cell carcinoma progression

Novel Therapeutic Targets in Ezh2-Inactivated Acoute Leukemia

HAS2 is a critical effector for AGL mediated regulation of tumor growth

Targeting Src kinase with dasatinib in thryoid cancer

Autophagy and RIP#-dependent necrosis in cancer chemotherapy

The Roles of APOBEC3 in Human Papillomavirus Infection and Oncogenesis

Role of hypoxic signaling in influencing T cell mediated cancer immunotherapy

Unique patterns of progression in recurrent pediatric Ependymoma

Metabolomics of primary and recurrent high grade gilomas: a role for the UPR

In Vivo modeling of salivary gland tumor formation progression

Genomic sequencing-based predictive biomarker development for targeted anti- cancer therapies

AGL, a glycogen debranching gene is a novel suppressor of bladder cancer growth

Role of HIF in regulating RNI splicing of HIF target genes

H3K9 histone demethylases in Ewing Sarcoma

Novel allosteric inhibitors of Eya 2 phosphate for treatment of metastatic breast cancer

Targeting autophagy for the treatment of triple negative breast cancer

Collaborative Project to increase accrual to cancer trials

Discovery of novel targets for young patients with colorectal cancer

Profile specific HDAC inhibitors for triple negative breast cancer

A dose escalation study of Ibrutinib with Lenalidomide for relapsed and refractory chronic lymphocytic leukemia/small lymphocytic lymphoma

Regulating EGFR protein levels by a deubiquitinaying enzyme in cancer cells

Development of Antibody as immunotherapy for pediatric brain tumors

Cancer Research Fellowship Program

Targeting Vascular Endothelial Growth Factor C in the cancer stem like population sensitizes breast Ccncer cells to oxidize stress and onhibits tumor progression

Protein Kinase C Delta and breast cancer therapeutics

Targeting Melanoma Photocinogeneses by blocking C+BP1

Pre-Clinical Investigation of Treprostinil as a Cemopreventive Agent for non-small cell lung cancer

Bronchial Somatic Chromosomal Alterations in lung cancer risk

Effects of Androgen Deprivation Therapy on geriatric health and physical function in men over 70 years of age with prostate cancer

Defining the role of SF 381 mutations in Leukemia

Targeting the Kynurenine Pathway to inhibit breast cancer metastases

Investigating the role of lymphangiogenesis and lymphovascular invasion in metastasis of postpartum breast cancer

Development of an Improved Classifier for Predicting Multiple Drug Classes and Molecular Targets for Tumor Subtypes

Role of alternative polyadenylation in estrogen receptor positive breast cancer

Novel Lung Cancer Therapeutics

Metformin Inhibits Metastasis in Triple Negative Breast Cancer

Characterizing the Function and Location of B Cells in Lung Cancer

Tumor cell Dissemination and Metastasis Initiation in Head and Neck Cancer

The Role of Eya in breast cancer metastic progression

Epignetic induction of erbB2/erbB3-targeting miRNAs in breast cancer

Colorado Cancer Research Program

The Role of PHF1 in the repressive activity of PRC2

Autophagy Dependence and Chloroquine Sensitivity in Metastatic Cancer